Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biphasic Insulin Aspart vs NPH/Regular Insulin in T2DM
NCT01889095Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2011
- Primary completion
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Tehran University of Medical Sciences. Started Jul 2011; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01889095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01889095.